UCB SA (UCBJF)
327.34
-9.73
(-2.89%)
USD |
OTCM |
Nov 17, 16:00
UCB Price : 327.34 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 327.34 | 327.34 | 327.34 | 327.34 | 13.00 |
| Nov 16, 2026 | 337.07 | 337.07 | 337.07 | 337.07 | 76.00 |
| Nov 13, 2026 | 318.75 | 318.75 | 318.75 | 318.75 | 956.00 |
| Nov 12, 2026 | 333.39 | 333.39 | 325.00 | 333.39 | 837.00 |
| Nov 11, 2026 | 314.48 | 314.48 | 314.48 | 314.48 | 27.00 |
| Nov 10, 2026 | 329.00 | 329.00 | 328.91 | 328.91 | 56.00 |
| Nov 09, 2026 | 328.00 | 331.75 | 327.53 | 328.20 | 1685.00 |
| Nov 06, 2026 | 320.00 | 325.84 | 320.00 | 325.84 | 105.00 |
| Nov 05, 2026 | 321.00 | 321.00 | 313.75 | 317.56 | 682.00 |
| Nov 04, 2026 | 321.09 | 321.09 | 321.09 | 321.09 | 130.00 |
| Nov 03, 2026 | 315.06 | 315.06 | 312.18 | 314.92 | 250.00 |
| Nov 02, 2026 | 305.31 | 316.84 | 305.31 | 313.81 | 3864.00 |
| Oct 30, 2026 | 317.00 | 317.34 | 297.82 | 317.34 | 60.00 |
| Oct 29, 2026 | 306.00 | 321.05 | 306.00 | 316.41 | 265.00 |
| Oct 28, 2026 | 305.42 | 305.84 | 305.42 | 305.84 | 80.00 |
| Oct 27, 2026 | 292.20 | 304.84 | 292.20 | 304.84 | 65.00 |
| Oct 26, 2026 | 305.59 | 305.59 | 305.59 | 305.59 | 31.00 |
| Oct 23, 2026 | 306.84 | 306.84 | 289.01 | 293.39 | 349.00 |
| Oct 22, 2026 | 285.75 | 297.34 | 285.75 | 297.34 | 7507.00 |
| Oct 21, 2026 | 250.34 | 250.34 | 250.34 | 250.34 | 52.00 |
| Oct 20, 2026 | 237.84 | 237.84 | 237.84 | 237.84 | 104.00 |
| Oct 19, 2026 | 237.84 | 237.84 | 237.84 | 237.84 | 15.00 |
| Oct 16, 2026 | 239.14 | 239.14 | 239.14 | 239.14 | 107.00 |
| Oct 15, 2026 | 240.24 | 240.24 | 240.24 | 240.24 | 10.00 |
| Oct 14, 2026 | 235.94 | 235.94 | 235.94 | 235.94 | 180.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1415.55 |
| Novo Nordisk A/S | 40.70 |
| Pfizer Inc. | 28.47 |
| Teva Pharmaceutical Industries Ltd. | 42.62 |
| Astellas Pharma, Inc. | 16.90 |
Price Related Metrics
| PE Ratio | 24.82 |
| PS Ratio | 6.389 |
| PEG Ratio | 0.0278 |
| Price to Free Cash Flow | 45.13 |
| Earnings Yield | 4.03% |
| Market Cap | 62.41B |
| PEGY Ratio | 0.0277 |
| Operating PE Ratio | 20.07 |
| Normalized PE Ratio | 24.61 |